|
|
 |
|
Viewing report
|
|
 |
 |
Alpha-2 Antiplasmin: US, Europe, Japan - Test Volume Forecasts by Country and Market Segment through 2018
Venture Planning Group, Sep 2011, Pages: 195
The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Alpha-2 Antiplasmin testing specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the Alpha-2 Antiplasmin testing closer to the patient, creating additional opportunities and challenges for suppliers.This report presents a detailed analysis of the Alpha-2 Antiplasmin testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test volume forecasts by country and market segment.
The report examines market applications of chromogenic substrates, monoclonal antibodies, immunoassays, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
Contains 195 pages and 8 tables
Customers who bought this item also bought
Global Alpha-2 Antiplasmin Market: US, Europe, Japan
The 2011 Coagulation Testing Market: US, Europe, Japan - Emerging Business Opportunities and Market Expansion Strategies for Suppliers
PT Testing: US, Europe, Japan - Test Volume Forecasts by Country and Market Segment through 2018
Fibrinogen: US, Europe, Japan - Test Volume Forecasts by Country and Market Segment through 2018
D-Dimer: US, Europe, Japan - Test Volume Forecasts by Country and Market Segment through 2018
Heparin: US, Europe, Japan - Test Volume Forecasts by Country and Market Segment through 2018
Thrombin Time: US, Europe, Japan - Test Volume Forecasts by Country and Market Segment through 2018
Global PT Testing Market: US, Europe, Japan
Global APTT Market: US, Europe, Japan
Global Antithrombin III Market: US, Europe, Japan
|
 |
|
|